The Next GameStop? 25 Stocks With High Short Interest

Wherever you find heavily shorted stocks, you'll probably find a trading frenzy. But beware: The music could stop at any moment.

Stock concept art
(Image credit: Getty Images)

Last year's meme stock trading frenzy might have come to an abrupt end in 2022, but the market remains rife with high-short-interest stocks that could be ripe for a short squeeze.

To recap: GameStop (GME, $108.91), which essentially kicked off last year's meme stock frenzy, ended 2021 up 688%. Indeed, it was tops among the best-performing stocks in the Russell 1000 index.

GME, along with Bed Bath & Beyond (BBBY, $14.06), AMC Entertainment (AMC, $18.84) and seemingly countless others, became meme stock darlings on social media platforms, most notably Reddit's r/wallstreetbets (WSB) subreddit. The retail raiding hordes would pile into stocks with high short interest – in other words, companies where many outstanding shares are being used to bet against the stock – with the intention of setting off a short squeeze.

Subscribe to Kiplinger’s Personal Finance

Be a smarter, better informed investor.

Save up to 74%
https://cdn.mos.cms.futurecdn.net/hwgJ7osrMtUWhk5koeVme7-200-80.png

Sign up for Kiplinger’s Free E-Newsletters

Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.

Profit and prosper with the best of expert advice - straight to your e-mail.

Sign up

The new year has thus far brought an end to all that.

Rising interest rates amid expectations for tighter monetary policy have hit growth stocks as a whole in 2022. But it has really clamped down on pricey high-short-interest meme stocks from last year.

GME, for example, has lost more than a quarter of its value so far in 2022. AMC is down by nearly a third. Shares in Robinhood Markets (HOOD, $14.40), whose free app became ground zero for meme-stock trading volume, have slumped almost 20%. The Roundhill Meme ETF (MEME, $11.93) is off 15% for the year-to-date.

The result is something of a shakeup in the list of stocks with highest short interest, as measured by the percentage of shares outstanding sold short. Although a number of meme stocks remain, many have been replaced by more traditional short bets.

A quick primer: Hedge funds and other market participants can bet against a stock by "shorting" it. But those bears sometimes get it wrong, and when they do, it can trigger an effect called a "short squeeze."

You can learn more about how short squeezes work in our explainer, but in brief, it's a phenomenon that occurs when buying pressure in a stock forces shorts to unwind their negative bets – which they can do only by purchasing the stock – fueling a virtuous cycle that sends shares aggressively higher.

To get a sense of where the next squeeze candidate might come from, we've put together a list of the 25 stocks with the highest short interest in the Russell 3000 Index, according to the latest data available from S&P Global Market Intelligence.

Note that Heron Therapeutics (HRTX, $8.14) currently tops the list. That's hardly unusual, however, and even something of a throwback to the pre-meme stock days. After all, biotechnology stocks with small market capitalizations have always been targets for short sellers. Heck, short interest in HRTX has been above 10% since mid-2018.

Biotechs figure prominently on the list, and certainly some of last year's meme stock favorites continue to hang on. Just be forewarned that this list is for informational purposes only.

Going long on a stock with high short interest thinking you're going to get rich off panic-buying by short sellers is an exceedingly dangerous idea. It's at least as risky as shorting stocks with high short interest in the first place.

When it comes to playing around with high short interest stocks, unless you are uncommonly lucky, let's just say the risks greatly outweigh the rewards.

Short interest data table

(Image credit: Data courtesy of S&P Global Market Intelligence)
Dan Burrows
Senior Investing Writer, Kiplinger.com

Dan Burrows is Kiplinger's senior investing writer, having joined the august publication full time in 2016.


A long-time financial journalist, Dan is a veteran of SmartMoney, MarketWatch, CBS MoneyWatch, InvestorPlace and DailyFinance. He has written for The Wall Street Journal, Bloomberg, Consumer Reports, Senior Executive and Boston magazine, and his stories have appeared in the New York Daily News, the San Jose Mercury News and Investor's Business Daily, among other publications. As a senior writer at AOL's DailyFinance, Dan reported market news from the floor of the New York Stock Exchange and hosted a weekly video segment on equities.


Once upon a time – before his days as a financial reporter and assistant financial editor at legendary fashion trade paper Women's Wear Daily – Dan worked for Spy magazine, scribbled away at Time Inc. and contributed to Maxim magazine back when lad mags were a thing. He's also written for Esquire magazine's Dubious Achievements Awards.


In his current role at Kiplinger, Dan writes about equities, fixed income, currencies, commodities, funds, macroeconomics, demographics, real estate, cost of living indexes and more.


Dan holds a bachelor's degree from Oberlin College and a master's degree from Columbia University.


Disclosure: Dan does not trade stocks or other securities. Rather, he dollar-cost averages into cheap funds and index funds and holds them forever in tax-advantaged accounts.